Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Pfizer financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Stock Price
$28.5
2024-10-29
Market Capitalization
$163.9 B
2024-08-26
Revenue
$62.6 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|
| Revenue | 100.3B | 58.5B | 63.6B | 62.6B |
| Cost of goods sold | 34.3B | 25.0B | 17.9B | 16.1B |
| Gross profit | 66.0B | 33.5B | 45.8B | 46.5B |
| Gross profit margin, % | 65.8% | 57.3% | 71.9% | 74.3% |
| General and administrative expense | 13.7B | 14.8B | 14.7B | 13.8B |
| Operating expense total | 31.0B | 32.5B | 37.8B | 24.2B |
| Depreciation and amortization | 3.6B | 4.7B | 5.3B | |
| Pre tax profit | 34.7B | 1.1B | 8.0B | 7.5B |
| Income tax expense | 3.3B | (1.1B) | (28.0M) | (266.0M) |
| Net Income | 31.4B | 2.2B | 8.1B | 7.8B |
| EPS | 5.5 | 0.4 | 1.4 | 1.4 |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |